Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Rigenera® effectively improves hair condition in Androgenetic Alopecia, and HairMetrix® tracks progress well.

Iron deficiency is linked to hair loss in adolescents, especially females, in northern Sudan.

Photobiomodulation improves the quality of life for people with hair loss.

Lymecycline may help with Frontal Fibrosing Alopecia but needs more research.

PRP is a safe and effective treatment for hair loss.

The serum is safe and helps treat premature greying of hair.

PRP therapy with a derma roller is a safe and effective treatment for female hair loss.

People with alopecia have a higher risk of thyroid cancer.

Oral isotretinoína effectively stabilizes frontal fibrosing alopecia.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Scalp biopsies greatly improved diagnosis and treatment for Black women with unclear alopecia.

PRP combined with minoxidil may help treat hair loss, but better methods and standardized practices are needed.

Pressure-induced hair loss is rare, often reversible, and early diagnosis is crucial to prevent complications.

Excimer laser therapy may help improve scarring alopecia symptoms and hair appearance.

CRT is more effective than oral minoxidil alone for treating hair loss.

Intralesional pentoxifylline effectively and safely treats alopecia areata, improving hair regrowth.

CO2 laser-associated PDT effectively treated therapy-resistant folliculitis decalvans.

Alopecia areata after COVID-19 vaccination is rare but important to recognize for timely treatment.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

The new scalp therapy shows promise for hair growth but needs more research.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

0.5% minoxidil mesotherapy is more effective and safe for hair growth in women with androgenetic alopecia than topical 2% minoxidil.

Current treatments for neutrophilic alopecias in children are limited and often ineffective, especially for males and those of Afro-Caribbean descent.

Adding cetirizine to minoxidil improves hair growth and thickness in women with androgenetic alopecia.

Dermoscopy is useful for accurately diagnosing syphilitic alopecia.

Cetosomal minoxidil is safer and as effective as alcohol-based minoxidil for male hair loss treatment.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

SVF may improve nanofat treatment for acne scars, but more research is needed.